ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
新股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
製藥與醫學研究概念
NaN
0.000
0.89%
漲家數:
3
跌家數:
1
平家數:
2
市盈率:
- -
高:
NaN
開:
NaN
低:
NaN
收:
NaN
成交量:
1,512.24萬
成交額:
461.66萬
市值:
59.64億
流通市值:
34.92億
資料載入中...
總覽
新聞資訊
IX生物製藥 - 提議合資建立美國製造和商業化基地的條款清單
美股速递
·
11/10
IX生物製藥新聞稿 - IX生物製藥獲得美國合作伙伴以加速Waferix產品組合的商業化
美股速递
·
11/10
IX生物製藥擬進行孖展,計劃籌集不少於500萬新元
美股速递
·
10/30
IX生物製藥擬發行股票籌集不少於500萬新元的資金 - 簽署股份發行協議
美股速递
·
10/28
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK6506/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK6506","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","market":"SI","secType":"PLATE","nameCN":"製藥與醫學研究概念","latestPrice":8.0366254e-7,"timestamp":1763370266006,"preClose":7.965757e-7,"halted":0,"volume":15122400,"delay":0,"changeRate":0.008897,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"11-17 17:16:00 SGT","open":7.968138e-7,"high":8.0366254e-7,"low":7.9062806e-7,"amount":4616595.9,"amplitude":0.016363,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763425800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763339400000,1763352000000],[1763355600000,1763370960000]],"pbRate":1.635055,"peRate":10.523089,"turnoverRate":0.012664,"increases":3,"decrements":1,"flats":3,"marketCap":5964393920,"floatMarketCap":3492039119.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","high":8.0366254e-7,"amplitude":0.016363,"preClose":7.965757e-7,"low":7.9062806e-7,"pbRate":"1.635055","latestPrice":8.0366254e-7,"volume":15122400,"delay":0,"open":7.968138e-7,"prevYearClose":0.02811279,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0.0001,"fiveDayClose":0,"twentyDayClose":0.0001,"sixtyDayClose":0.0002,"secType":"PLATE","market":"SI","turnoverRate":0.012664,"peRate":10.523089,"marketCap":5964393920,"floatMarketCap":3492039119.25,"timestamp":1763370266006,"nameCN":"製藥與醫學研究概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK6506\",,,,undefined,":{"bkCode":"BK6506","up":3,"down":1,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK6506\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172240294","title":"IX生物製藥 - 提議合資建立美國製造和商業化基地的條款清單","url":"https://stock-news.laohu8.com/highlight/detail?id=1172240294","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172240294?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 07:23","pubTimestamp":1762730595,"startTime":"0","endTime":"0","summary":"IX生物制药 - 提议合资建立美国制造和商业化基地的条款清单","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6506","42C.SI","BK6079"],"gpt_icon":0},{"id":"1122893081","title":"IX生物製藥新聞稿 - IX生物製藥獲得美國合作伙伴以加速Waferix產品組合的商業化","url":"https://stock-news.laohu8.com/highlight/detail?id=1122893081","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122893081?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 07:23","pubTimestamp":1762730588,"startTime":"0","endTime":"0","summary":"IX生物制药新闻稿 - IX生物制药获得美国合作伙伴以加速Waferix产品组合的商业化","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6079","42C.SI","BK6506"],"gpt_icon":0},{"id":"1139139125","title":"IX生物製藥擬進行孖展,計劃籌集不少於500萬新元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139139125","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139139125?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 18:46","pubTimestamp":1761821172,"startTime":"0","endTime":"0","summary":"IX生物制药拟进行融资,计划筹集不少于500万新元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6079","BK6506","42C.SI"],"gpt_icon":0},{"id":"1113241098","title":"IX生物製藥擬發行股票籌集不少於500萬新元的資金 - 簽署股份發行協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1113241098","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113241098?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 09:17","pubTimestamp":1761614228,"startTime":"0","endTime":"0","summary":"IX生物制药拟发行股票筹集不少于500万新元的资金 - 签署股份发行协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6506","42C.SI","BK6079"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}